Lyonbiopôle Auvergne-Rhône-Alpes

𝗩𝗼𝘂𝘀 𝘀𝗼𝘂𝗵𝗮𝗶𝘁𝗲𝘇 𝗱𝗲𝘃𝗲𝗻𝗶𝗿 𝗮𝘂𝗱𝗶𝘁𝗲𝘂𝗿 𝗶𝗻𝘁𝗲𝗿𝗻𝗲 𝗜𝗦𝗢 𝟭𝟯𝟰𝟴𝟱 ? Formez-vous avec Novéka ! et montez en compétence sur la gestion de la qualité des dispositifs médicaux ! ✅ 2 jours pour maîtriser les bases de l’audit interne. Une formation accessible, pratique et opérationnelle animée par Laure OLIVER, experte avec 25 ans d'expérience en dispositifs médicaux. 𝗢𝗯𝗷𝗲𝗰𝘁𝗶𝗳𝘀 𝗱𝗲 𝗹𝗮 𝗳𝗼𝗿𝗺𝗮𝘁𝗶𝗼𝗻 : 🔹 Comprendre et appliquer la norme ISO 13485:2016 🔹 Conduire efficacement un audit interne ou fournisseur 🔹 Rédiger un rapport d’audit pertinent et structuré Mise en pratique : études de cas, jeux de rôle et exercices concrets pour une immersion totale. 📍 En présentiel (Saint-Etienne, 42) – 14h de formation ⚠️ 𝗡𝗼𝗺𝗯𝗿𝗲 𝗱𝗲 𝗽𝗹𝗮𝗰𝗲𝘀 𝗹𝗶𝗺𝗶𝘁𝗲́ - 𝗗𝗮𝘁𝗲 𝗹𝗶𝗺𝗶𝘁𝗲 𝗱'𝗶𝗻𝘀𝗰𝗿𝗶𝗽𝘁𝗶𝗼𝗻 : 𝟮𝟳 𝗺𝗮𝗿𝘀 📩 Réservez votre place dès maintenant : formation@noveka.org ℹ️ Toutes les informations ici : https://lnkd.in/dySH2eN8 Ne manquez pas cette opportunité de vous former auprès d’une experte du secteur !

📄 [Communiqué de presse] – MaaT Pharma reçoit un avis positif du Comité Pédiatrique de l'EMA pour le plan d'investigation pédiatrique de MaaT013 dans le traitement de la maladie aiguë du greffon contre l’hôte 🩸 Voir le communiqué de presse : https://lnkd.in/e5Sc4EaS #EMA #MaaT013 #EMA #aGvH #Pédiatrique #Cancer #Oncologie

🚀 Nous sommes ravis de vous dévoiler aujourd'hui les 9 finalistes du Concours de l’Innovation 2025 ! Un grand bravo aux start-ups qui auront l'opportunité de pitcher lors de la 13ème édition de Medi'Nov Connection : - Gaël Volpi, Spine DynamiX - Camille Srour, PhD, SC MEDICA - Mohammad Ojaroudi, COGNISCAN - Maya BERTRON, iPerf Connecting - Thomas Charrel, Veinsound - Marine Menut, CISTEN - Stéphane Luong, SWIFT IMAGING EUROPE LTD - Eduardo W. Jørgensen de Vizcarrondo, Medicsen - Lugan Flacher, DrugOptimal Venez nombreux pour assister à leurs présentations le mercredi 26 mars, de 16h30 à 17h30 au Centre des Congrès de Lyon. #Medinov #MedTech #Innovation #Santé

𝗗𝗲𝘀𝘀𝗶𝗻𝘁𝗲𝘆 𝘁𝗮𝗸𝗲𝘀 𝗮𝗰𝘁𝗶𝗼𝗻 𝗶𝗻 𝗿𝗲𝗯𝘂𝗶𝗹𝗱𝗶𝗻𝗴 𝗨𝗸𝗿𝗮𝗶𝗻𝗲’𝘀 𝗰𝗿𝗶𝘁𝗶𝗰𝗮𝗹 𝗵𝗲𝗮𝗹𝘁𝗵𝗰𝗮𝗿𝗲 𝗶𝗻𝗳𝗿𝗮𝘀𝘁𝗿𝘂𝗰𝘁𝘂𝗿𝗲 We are honoured to officially announce that Dessintey has been selected as one of the 𝟭𝟵 𝗹𝗮𝘂𝗿𝗲𝗮𝘁𝗲𝘀 𝗼𝗳 𝘁𝗵𝗲 #𝗙𝗼𝗻𝗱𝘀𝗨𝗸𝗿𝗮𝗶𝗻𝗲, a €200M initiative supporting Ukraine’s reconstruction. The announcement has taken place in Bercy, in the presence of: 🔹 Eric Lombard, Ministère de l’Économie, des Finances et de la Souveraineté industrielle et numérique (Minister of Economics and Finance) 🔹 Jean-Noël Barrot, Ministère de l'Europe et des Affaires étrangères (Minister for Europe and Foreign Affairs) 🔹 Yulia Svyrydenko, Cabinet of Ministers of Ukraine (First Deputy Prime Minister of Ukraine) As a medtech pioneer in intensive rehabilitation, Dessintey will equip 45 hospitals across Ukraine with cutting-edge medical devices to support the recovery of war-wounded civilians and soldiers. Our project "Rehab for Ukraine" addresses a critical need: 🧠 Supporting neuroplasticity for faster functional recovery 🦾 Restoring mobility and improving quality of life for amputees and injured patients 💡 Providing innovative self-rehabilitation solutions to tackle the shortage of medical professionals With our IVS3 & IVS4 technologies (Intensive Visual Simulation) and SRT5 (Self-Rehabilitation Technology), combined with a hybrid training program for healthcare professionals, we are committed to making a real difference on the ground. A huge thank you to the French and Ukrainian authorities for their trust. We are proud to contribute to this essential mission of resilience and reconstruction. Congratulations to all the laureates especially those in the healthcare sector: C3Medical Consulting DMS Imaging | DMS Group ELLIPSE GROUP & Ginger INTERNATIONAL, Resilience Orthopedics SCHILLER Medical Sonoscanner - Premium Ultrasound Scanners cc Direction générale du Trésor (French Treasury) #FondsUkraine #FranceUkraine

🚀 MSInsight Secures €1.6 Million in Funding to Advance Precision Oncology! 🚀 We are proud to announce that MSInsight has successfully completed a €1.6 million fundraising round to accelerate the development and clinical validation of MSIcare, our cutting-edge diagnostic solution for microsatellite instability (MSI) detection. This milestone strengthens our mission to revolutionize cancer diagnostics by leveraging AI-powered genomic analysis to improve treatment decisions and patient outcomes. 🔬 A Huge Thank You to Our Investors & Partners We are incredibly grateful for the trust and support of our funding partners: 🔹 Calyseed 🔹 Plateau de Saclay Business Angels 🔹 Yes Invest 🔹 Capital Cell And a special thanks to our advisors and academic partners who made this fundraising possible: 💼 MCE CARREL AVOCATS, ODICEO, ICOSA 🏥 Greater Paris University Hospitals - AP-HP, INSERM, Inserm Transfert, Sorbonne Université, CRSA PARIS We are fortunate to be part of an exceptional ecosystem in France, surrounded by key players who support innovative projects like ours: 🌱 WILCO Healthcare 🔬 Agoranov 🧬 France Biotech 💡Paris Saclay Cancer Cluster (PSCC) ⚕️ Lyonbiopôle Auvergne-Rhône-Alpesôle 🏥 Medicen Paris Region 💰 Bpifrance 🏦 CIC & BNP Paribas 📊 Voisin Consulting Life Sciences (VCLS) x Neighborhood 🧪 PULSALYS 🔬 The Innovators Behind MSInsight This success is the result of the dedication and expertise of our historical co-founders: 🔬 Arnaud Cutivet, Alex Duval, Toky Ratovomanana, Florence Renaud, Ada Collura, Luc Marchand, Patrick Aubry, Bertrand Levitte, Olivier Exertier And the team members who bring this vision to life every day: 💙 Mélyna K., Mathieu Daniere, Sati Saakian, Seif S., Balthazar RAFFY, Sydney Normand 💡 What’s Next? With this funding, MSInsight is: ✅ Advancing MSIcare toward CE-IVD certification ✅ Expanding its clinical validation across multiple cancers ✅ Strengthening partnerships to bring cutting-edge diagnostics to market A huge thank you to everyone who has been part of this journey. We are just getting started! 🚀 #MSInsight #PrecisionMedicine #OncologyInnovation #CancerDiagnostics #MSIcare #AIinHealthcare #NGS #MedTech #Biotech

💊 France Bioproduction Congress 2025: explore the key challenges shaping the future of bioproduction! 📅 19-20 March 2025 📍 Congress Centre of Tours, France Register now 👉 https://lnkd.in/dEqVyA3T 📅 This exceptional edition invites you to dive into four key themes, at the intersection of innovation, artificial intelligence, and therapeutic needs. ⏩ 1. Bioproduction : Current Challenges and future perspectives ⏩ 2. Accelerating bioproduction for patient ⏩ 3. The revolution of bioproduction in the age of AI ⏩ 4. New bioproduction models for tomorrow's biotherapies 📌 Don’t miss the opportunity to network with experts and industry leaders! 👉 Join us now for this landmark event: ✔️ Discover the latest advancements in bioproduction ✔️ Participate in hands-on workshops and discussions ✔️ Meet key players in the industry 🌐 Registrations & info: https://lnkd.in/dEqVyA3T Organized by POLEPHARMA and Medicen Paris Region Under the Presidency of Jacques Brom, LFB Managing Director and France Bioproduction Congress President #CFB25 #Bioproduction #Biopharmaceuticals #FranceBioproduction #Innovation #Bioproduction #AI #Health #Biotherapies #Biomanufacturing #Biologics #ATMP

📢 Osivax Secures Strategic Funding to Accelerate the Development of its Influenza Vaccine Candidates To read the full press release ➡️ https://lnkd.in/es7kSYrB #Biotech #Funding #Investment #HealthInnovation